Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia

Stock Information for Eyenovia Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eyenovia Inc.

Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering
Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis
Eyenovia Prices Public Offering of Common Stock
Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study
Eyenovia Announces Publication of its PG21 Phase II Trial Results Demonstrating Robust IOP Lowering Effect and Patient Usability
Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study
Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics - Emerging Consolidated Expectations, Analyst Ratings
Eyenovia Announces FDA Acceptance of MicroStat IND Application for Mydriasis

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.